Welcome from the Chair
Welcome to the Department of Pathology at Stony Brook Medicine. This website highlights our achievements in medical education, basic and translational research, and diagnostic service. These pages also include important information related to our Residency and Fellowship training programs in Anatomic and Clinical Pathology.

Members of our department serve as regional and national authorities in clinical and anatomic pathology, as innovators in graduate student, medical student, and resident education, and as national and international authorities in both basic and translational research. The department is both a basic science and clinical department and provides comprehensive service in all aspects of laboratory medicine, as well as in surgical pathology and cytopathology. Our dynamic faculty members are bridging the gap from bench to bedside research with the goal of improving the effectiveness of clinical diagnosis and patient care for the citizens of New York and the broader community. Read More

 
Residency Program

The goal of the Stony Brook Medicine Department of Pathology Residency Training Program is to provide an excellent educational experience such that program graduates possess the knowledge, skill and attitude for the successful independent practice of pathology and for the life-long pursuit of learning. Our program provides comprehensive training in anatomic pathology (AP) and clinical pathology (CP), combined or individually, as well as in research and education. Read More

In the News

 

  • Stony Brook Researchers Develop New Urine Test To Detect Bladder Cancer Read More

  • New Non-Invasive Test Can Detect Bladder Cancer Read More

  • Reducing Barriers, Minimizing Gaps: A Q&A With Sui Zee, MD, FASCP Read More

  • Welcome Rekha Reddy, DMD, Clinical Assistant Professor and Director of Oral Pathology Read More

  • KRAS Gene May Drive Immune 'Evasion' In Pancreatic Cancer Read More

  • Study: Lowering The Activity of KRAS Gene Can Help Fight Pancreatic Cancer Read More

  • Lowering KRAS Activity May Lead to Improved Therapy Response in Pancreatic Cancer Read More